You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
COMPREHENSIVE OUTCOME SCALE FOR OUTPATIENT PSYCHIATRY
SBC: PSYCH PRODUCTS PRESS Topic: N/AN/A
SBIR Phase I 1998 Department of Health and Human Services -
SBIR Phase I: Acoustic Microcavitation Assisted Fine Cleaning of Post-Chemical Mechanical Plana
SBC: RITEC Inc Topic: N/AN/A
SBIR Phase I 1998 National Science Foundation -
Drop Out Computer Training Options Research (DOCTOR) CD Rom Products Development
SBC: SEACORP, LLC Topic: N/AN/A
SBIR Phase I 1998 Department of Education -
Calcaftor, a CFTR stabilizer for Cystic Fibrosis treatment
SBC: CALISTA THERAPEUTICS INC Topic: NIDDKDESCRIPTION (provided by applicant): Calista Therapeutics has invented Calcaftor, a first-in-class peptide drug that can treat all Cystic Fibrosis (CF) patients. Calcaftor is validated in the gold standard pre-clinical model of CF using F508 -CFTR lung tissue harvested from CF transplant patients. Results from this model demonstrated a gt25 hour duration of action that enables once daily inhaled n ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Inter-alpha-inhibitors in Hypoxic-Ischemic Brain Injury
SBC: PROTHERA BIOLOGICS, INC. Topic: NINDSDESCRIPTION (provided by applicant): Neonatal hypoxia-ischemia (HI) remains a major cause of acute perinatal brain injury, leading ultimately to neurologic dysfunction manifesting as cerebral palsy, mental retardation, and epilepsy. Cerebral oxygen deprivation and/or reduced blood flow due to umbilical cord occlusion, prolonged labor, and/or intracranial hemorrhage produce an inflammatory respons ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
IGF::OT::IGF High-Impact Substance Abuse Prevention Technologies. SBIR Phase I. Period of Performance 7/16/2014-1/15/2015
SBC: Pro-Change Behavior Systems, Inc. Topic: NIDAThe overarching objective of this project is to develop an innovative technological tool that will facilitate the implementation of an evidence-based substance abuse prevention program and related health behavior risk programs among military personnel. PUBLIC HEALTH RELEVANCE
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health